Andrew G Scott

Title: Innovator Spotlight: Andrew G. Scott

Introduction: Andrew G. Scott, an accomplished inventor based in Palo Alto, CA, is celebrated for his innovative contributions to tobacco cessation technologies. His work primarily focuses on developing methods to reduce tobacco dependency, showcasing his commitment to public health and wellness.

Latest Patents: Andrew G. Scott holds a notable patent titled "Method and apparatus for reducing the incidence of tobacco use." This patent introduces an apparatus designed for the transdermal delivery of a nicotine-based agent to users of tobacco or nicotine. It incorporates a microprojection member featuring numerous microprojections intended to penetrate the stratum corneum of the user’s skin. The microprojection member is coated with a biocompatible substance that contains the nicotine-based agent, effectively aiding users in their efforts to quit smoking.

Career Highlights: Andrew is currently affiliated with Alza Corporation, a renowned company known for its innovations in drug delivery systems. Through his work at Alza, he has been instrumental in advancing pharmaceutical technology aimed at improving the effectiveness and safety of medications.

Collaborations: Throughout his career, Andrew has had the opportunity to collaborate with esteemed colleagues, including Michel J. N. Cormier and Robert M. Gale. These partnerships have further enriched his research and development endeavors, contributing to the advancements in nicotine delivery systems.

Conclusion: Andrew G. Scott's work exemplifies the impact of innovation in addressing public health challenges. With his significant developments in nicotine transdermal systems, he continues to influence the field of tobacco cessation, providing critical solutions for individuals seeking to overcome addiction. His dedication and ingenuity mark him as a noteworthy figure in the realm of inventors.